July 17 (Reuters) – An experimental drug from Eli Lilly (LLY.N) works best if Alzheimer’s patients are treated as early as possible, ideally before they develop symptoms of the brain-wasting disease,… [+5000 chars]Read More
Lilly drug slows Alzheimers by 60 for mildly impaired patients in trial Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZZ466LDVB5JX5OK6ZYEZOVZ3SY.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/WUNSYYBQTRJV7BA2JJGZWUTSYI.jpg)